Published: 6 March 2014

Publications

Quarterly Summary of Medsafe’s Early Warning System Communications

This article is more than five years old. Some content may no longer be current.

Prescriber Update 35(1): 11
March 2014

The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices.

More information about the early warning system can be found on the Medsafe website (www.medsafe.govt.nz/safety/SafetyCommunications.asp).

Date Communication Topic
3 December 2013 Alert Black salve - buyer beware
3 February 2014 Monitoring M² logo Amitriptyline and a possible risk of peripheral coldness (cold hands and/or feet) or Raynaud's phenomenon added to the medicines monitoring (M² logo) scheme
11 February 2014 Alert Utrogestan (progesterone) formulation change - important information for patients with a peanut allergy
27 February 2014 Monitoring Effectiveness of emergency contraception may be reduced in women weighing more than 70kg


If you would like to receive Medsafe's early warning communications you can subscribe at www.medsafe.govt.nz/profs/subscribe.asp

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /